Skip to main content
Fig. 5 | Hereditas

Fig. 5

From: Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway

Fig. 5

Arecoline treatment affects migration and invasion by HepG2 hepatoma cells. A Changes in scratch distance in HepG2 hepatoma cells treated with the indicated concentrations of arecoline. B Changes in migration area in HepG2 hepatoma cells treated with the indicated concentrations of arecoline. C Changes in migration rate in HepG2 hepatoma cells treated with the indicated concentrations of arecoline. D Changes in invasion ability in HepG2 hepatoma cells treated with the indicated concentrations of arecoline, as assessed in a transwell assay. E–F Migration and invasion ability of HepG2 hepatoma cells treated with the indicated concentrations of arecoline, as assessed in a wound healing Vs 0d, ap < 0.05; vs 1d, bp < 0.05; vs 3d, cp < 0.05

Back to article page